ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Biodesix Inc

Biodesix Inc (BDSX)

1.34
0.05
(3.88%)
Closed December 14 4:00PM
1.341
0.001
(0.07%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.34
Bid
1.19
Ask
1.39
Volume
223,491
1.28 Day's Range 1.37
1.11 52 Week Range 2.21
Market Cap
Previous Close
1.29
Open
1.29
Last Trade
5
@
1.35
Last Trade Time
Financial Volume
$ 295,849
VWAP
1.3238
Average Volume (3m)
452,156
Shares Outstanding
145,467,295
Dividend Yield
-
PE Ratio
-3.74
Earnings Per Share (EPS)
-0.36
Revenue
49.09M
Net Profit
-52.15M

About Biodesix Inc

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
-
Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was $1.29. Over the last year, Biodesix shares have traded in a share price range of $ 1.11 to $ 2.21.

Biodesix currently has 145,467,295 shares outstanding. The market capitalization of Biodesix is $187.65 million. Biodesix has a price to earnings ratio (PE ratio) of -3.74.

BDSX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.032.290076335881.311.391.242867551.32739185CS
4-0.04-2.898550724641.381.51.117284361.26227373CS
12-0.45-25.13966480451.791.851.114521561.38003297CS
26-0.19-12.41830065361.532.041.112846771.45402051CS
52-0.22-14.10256410261.562.211.112119361.49855782CS
156-3.52-72.42798353914.865.99730.9551945721.82763981CS
260-12.25-90.139808682913.5931.990.9551765614.30632929CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WKEYWISeKey International Holdings AG
$ 7.84
(139.02%)
75.53M
IPHAInnate Pharma SA
$ 3.00
(93.55%)
13.59M
AVLDirexion Daily AVGO Bull 2X Shares
$ 33.67
(48.92%)
658.55k
LOOPLoop Industries Inc
$ 1.8092
(47.09%)
82.56M
AVGXDefiance Daily Target 2X Long AVGO ETF
$ 31.49
(46.67%)
3.55M
RPTXRepare Therapeutics Inc
$ 1.765
(-55.54%)
4.59M
INOInovio Pharmaceuticals Inc New
$ 2.31
(-38.56%)
9.59M
XXII22nd Century Group Inc
$ 0.048
(-34.69%)
41.72M
FLGCFlora Growth Corporation
$ 1.30
(-34.34%)
4.01M
WTOUTime Limited
$ 0.281
(-32.74%)
3.79M
NVDANVIDIA Corporation
$ 134.25
(-2.25%)
228.17M
SOUNSoundHound AI Inc
$ 16.905
(23.66%)
158.74M
TRUGTruGolf Holdings Inc
$ 0.6794
(30.93%)
138.19M
RGTIRigetti Computing Inc
$ 7.155
(19.85%)
122.67M
AVGOBroadcom Inc
$ 224.80
(24.43%)
117.74M

BDSX Discussion

View Posts
PonkenPlonken PonkenPlonken 1 week ago
Mr Schuler is buying shares again
๐Ÿ‘๏ธ0
tw0122 tw0122 1 month ago
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
๐Ÿ‘๏ธ0
tw0122 tw0122 1 month ago
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
๐Ÿ‘๏ธ0
AJ Freely AJ Freely 1 year ago
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
๐Ÿ‘๏ธ0
1hot toddy 1hot toddy 2 years ago
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
๐Ÿ‘๏ธ0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
๐Ÿ‘๏ธ0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
๐Ÿ‘๏ธ0
subslover subslover 2 years ago
Earnings look good.
๐Ÿ‘๏ธ0
subslover subslover 2 years ago
Earnings look good.
๐Ÿ‘๏ธ0
MiamiGent MiamiGent 2 years ago
BDSX Has news this morning!

The contract covers the companyโ€™s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGSโ„ข testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
๐Ÿ‘๏ธ0
carusso carusso 2 years ago
Not so much...
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
LET'S GO BDSX !!!!!
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
๐Ÿ‘๏ธ0
crudeoil24 crudeoil24 2 years ago
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Companyโ€™s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
๐Ÿ‘๏ธ0
Leg58 Leg58 2 years ago
US based company is quietly trending up. IMHO.
GLTA
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock